SRTA

Strata Critical Medical INC

-$16.3M

Net Activity

Institutions Holding

125

Popularity Rank

#3978

Avg Weight

0.13%

Total Value

$234.7M

Ownership Trend

125 institutions currently hold SRTA, with 65 net buyers and 53 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

53

Net Buying Institutions

65

Key Holders

View all 125 holding institutions

Quarterly Activity

Recent Activity

+$149.3M

Total Buy Value

$50.5M

Total Sell Value

New buy17
Trim36
Add48
Sold out17

65

Net Buyers

53

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

0

Active 5%+ Holders

Data as of 2026-07-08
Reporting PersonTypeFiling Date% of Class
ARK Investment Management LLC13G/A2026-07-083.2%

View all Schedule 13D/13G filings

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding STRATA CRITICAL MEDICAL INC (SRTA)?
Major stakeholders currently include ARK Investment Management LLC ($31.2M), Third Point LLC ($20.9M), BlackRock, Inc. ($19.1M). Based on the latest 13F filings, there are a total of 125 tracked investment funds and institutions maintaining positions in SRTA.
What is the overall institutional sentiment toward SRTA recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $16.3M, driven by 65 managers accumulating shares while 53 reduced their exposure.
Which institutions have been selling or reducing their SRTA positions?
In the latest period, 36 funds trimmed their holdings, and 17 managers completely exited their positions. The aggregate reported sell value was $50.5M.
Are there any notable investors adding SRTA to their portfolios?
Yes, buying activity remains notable. 17 institutions opened new positions in {ticker}, and 48 existing holders added to their shares. The total reported buy value for the quarter amounted to $149.3M.

Related Stocks